跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
STASON-LETROZOLE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
STASON-LETROZOLE
Authorized
STANDARD
STASON-LETROZOLE
VPI Pharmaceuticals Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2668785df0d4d9cd
Company
VPI Pharmaceuticals Inc
Type
Standard
Approval Details
Approval Id
2668785df0d4d9cd
Drug Approval Canada Name
STASON-LETROZOLE
Product Name
STASON-LETROZOLE
Status
Cancelled Pre Market
Status Date
2018-06-27
Din
02431335
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L02BG04 LETROZOLE
Atc Name
l 02 bg 04
Aig Number
0132937001
Company Name
VPI Pharmaceuticals Inc
Company Address
16667 Hymus Boulevard, Kirkland, Quebec, Canada, H9H 4R9
Company Detail Path
/organization/vpi-pharmaceuticals-inc
Company Information
Pharmaceutical Company Name
VPI Pharmaceuticals Inc
Country Name
Canada
Province Name
Quebec
City Name
kirkland,quebec,country_ca
Address
16667 boul Hymus
Active Ingredients
LETROZOLE
2.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2668785df0d4d9cd
Type
Standard
Back to Health Canada Approvals